Treatment of tuberculous meningitis in Turkey

Scand J Infect Dis. 1995;27(2):135-8. doi: 10.3109/00365549509018993.

Abstract

A prospective study was performed on 72 cases of tuberculous meningitis studying various treatments. 37 patients were treated with a combination of isoniazid, rifampicin, pyrazinamide and streptomycin for 2 months, followed by a combination of isoniazid and rifampicin for 6 months. 35 patients were treated with various combinations of antituberculous drugs for 12-16 months. Disappearance of symptoms took (mean) 17 days. Mean duration of therapy for the hospitalized patients was 36 +/- 4 days. Seven (9.7%) patients died, 5 in the short-course therapy group and 2 in the long-course therapy group. Sequelae persisted in 18 (31%) cases, 8 of which cases were in the short-course therapy group and 10 in the long-course therapy group. No relapse was observed in either of the groups.

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents*
  • Antitubercular Agents / therapeutic use*
  • Drug Therapy, Combination / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects
  • Prognosis
  • Prospective Studies
  • Time Factors
  • Tuberculosis, Meningeal / drug therapy*
  • Tuberculosis, Meningeal / mortality
  • Turkey / epidemiology

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents